Published date: 29 November 2018
Last edited date: 29 November 2018
Closed future opportunity - This means that a potential contract has passed its approach to market date. A buyer can choose to consider any supplier interest or convert this notice into an opportunity ready for live procurement.
Contract summary
Industry
Pharmaceutical products - 33600000
Location of contract
Any region
Value of contract
£240,000,000
Procurement reference
CM/PHG/17/5531
Published date
29 November 2018
Approach to market date
1 June 2019
Contract start date
1 February 2020
Contract end date
31 January 2022
Procedure type
Open procedure (above threshold)
Any interested supplier may submit a tender in response to an opportunity notice.
This procedure can be used for procurements above the relevant contract value threshold.
Contract is suitable for SMEs?
Yes
Contract is suitable for VCSEs?
No
Description
NHS National Framework Agreement for Generic Pharmaceuticals - Wave 12.
Regions:
Central and South West (CESW);
North West and Eastern and North London (NWLN); and
South East and South London and North East and Yorkshire (LSNE).
More information
Spend profile
| Financial year | Budget |
|---|---|
| 2020/2021 | £120,000,000 |
| 2021/2022 | £120,000,000 |
Share this notice
Approach to market date: 1 June 2019
All content is available under the
